Evidence review of e-cigarettes and heated tobacco products 2018 Page 1 Evidence review of
e-cigarettes and heated tobacco products 2018 A report commissioned by Public Health …

Despite major efforts to reduce atherosclerotic cardiovascular disease (ASCVD) burden with
conventional risk factor control, significant residual risk remains. Recent evidence on non …

Background: Contemporary data on the prevalence of e-cigarette use in the United States
are limited. Objective: To report the prevalence and distribution of current e-cigarette use …

Importance The use of electronic cigarettes (e-cigarettes) and other noncigarette tobacco
products may increase the odds of cigarette initiation, even among low-risk youths. Objective …

Cardiovascular disease (CVD) is the leading cause of death globally. Advancements in the
treatment of CVD have reduced mortality rates, yet the global burden of CVD remains high …

Toxicology is undergoing a digital revolution, with mobile apps, sensors, artificial
intelligence (AI), and machine learning enabling better record-kee**, data analysis, and …

Objectives A heat-not-burn (HNB) tobacco product, IQOS, was first launched in Japan and
Italy as test markets and is currently in commerce in 30 countries. Using two data sources …

Objective To examine whether the increase in use of electronic cigarettes in the USA, which
became noticeable around 2010 and increased dramatically by 2014, was associated with a …

Va** and electronic cigarette (e-cigarette) use have grown exponentially in the past
decade, particularly among youth and young adults. Cigarette smoking is a risk factor for …

Inhalation of the toxic smoke produced by combusting tobacco products, primarily cigarettes,
is the overwhelming cause of tobacco-related disease and death in the United States and …